Advanced Medical Solutions Group plc (AQA.F)
- Previous Close
2.1000 - Open
2.1200 - Bid 2.1800 x 1000000
- Ask 2.2400 x 1000000
- Day's Range
2.1200 - 2.1200 - 52 Week Range
2.0400 - 3.0600 - Volume
6 - Avg. Volume
4 - Market Cap (intraday)
477.929M - Beta (5Y Monthly) 0.56
- PE Ratio (TTM)
26.50 - EPS (TTM)
0.0800 - Earnings Date --
- Forward Dividend & Yield 0.03 (1.31%)
- Ex-Dividend Date May 30, 2024
- 1y Target Est
--
Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and hernia mesh fixation device that allows for the accurate laparoscopic internal application of its cyanoacrylate adhesive to attach hernia meshes under the LiquiBandFix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobials, and hydrocolloids, as well as wound care products under the ActivHeal brand, as well as under white-label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.
www.admedsol.comRecent News: AQA.F
Performance Overview: AQA.F
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AQA.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AQA.F
Valuation Measures
Market Cap
473.42M
Enterprise Value
414.18M
Trailing P/E
24.95
Forward P/E
19.05
PEG Ratio (5yr expected)
4.48
Price/Sales (ttm)
3.14
Price/Book (mrq)
1.61
Enterprise Value/Revenue
3.28
Enterprise Value/EBITDA
12.38
Financial Highlights
Profitability and Income Statement
Profit Margin
12.59%
Return on Assets (ttm)
4.14%
Return on Equity (ttm)
6.61%
Revenue (ttm)
126.21M
Net Income Avi to Common (ttm)
15.89M
Diluted EPS (ttm)
0.0800
Balance Sheet and Cash Flow
Total Cash (mrq)
60.16M
Total Debt/Equity (mrq)
3.74%
Levered Free Cash Flow (ttm)
997.88k
Company Insights: AQA.F
AQA.F does not have Company Insights